Company Filing History:
Years Active: 1992-2013
Title: Joan Marie Caroon: Innovator in Pharmaceutical Chemistry
Introduction
Joan Marie Caroon is a distinguished inventor based in Mountain View, CA (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. Her work primarily focuses on compounds that modulate the P2X7 purinergic receptor, which is crucial in various disease treatments.
Latest Patents
Among her latest patents is the innovative work on dihydropyrimidone amides as P2X7 modulators. This patent details compounds of the formula I or pharmaceutically acceptable salts thereof, with specific definitions for m, n, R, and other variables. The patent also discloses methods for making these compounds and their applications in treating diseases associated with the P2X7 purinergic receptor.
Career Highlights
Joan has worked with notable companies in the pharmaceutical industry, including Roche Palo Alto LLC and Syntex (U.S.A.) Inc. Her experience in these organizations has allowed her to develop and refine her expertise in drug development and innovation.
Collaborations
Throughout her career, Joan has collaborated with esteemed colleagues such as Francisco Javier Lopez-Tapia and Keith Adrian Murray Walker. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Joan Marie Caroon is a prominent figure in pharmaceutical innovation, with a strong portfolio of patents and collaborations. Her work continues to impact the field significantly, paving the way for new treatments and advancements in medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.